During the past decade, Grupo Oncologico Cooperativo del Sur conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grupo Oncologico Cooperativo del Sur" are "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Grupo Oncologico Cooperativo del Sur" in a lesser frequency.

Most popular intervention types in "Grupo Oncologico Cooperativo del Sur" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (1 trials), "fluorouracil" (1 trials), "ifosfamide" (1 trials), "leucovorin calcium" (1 trials) and "trimetrexate glucuronate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grupo Oncologico Cooperativo del Sur" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grupo Oncologico Cooperativo del Sur". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Grupo Oncologico Cooperativo del Sur, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grupo Oncologico Cooperativo del Sur, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".